Viewing Study NCT07142551


Ignite Creation Date: 2025-12-24 @ 11:39 PM
Ignite Modification Date: 2026-01-14 @ 6:07 PM
Study NCT ID: NCT07142551
Status: NOT_YET_RECRUITING
Last Update Posted: 2025-12-17
First Post: 2025-08-19
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Supraphysiologic Testosterone Priming Induces Darolutamide Extended Response
Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Metastatic Castration-resistant Prostate Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Prostate Cancer View